Stock listing
Frankfurt:88Q 4basebio PLC Aktie
German listing (Frankfurt) of 4basebio PLC · home listing LSE:4BB
Follow 4basebio PLC into a list and get an email when it puts out news.
Share price · FWB:88Q
€6.00 EUR -0.35 (-5.5%)
Close on Oct 30, 2026
- Day range
- €6.00 – €6.20 EUROct 30, 2026
- Market cap
- €92.91M EURAt the close on Oct 30, 2026 · price × 15.48M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:4BB · Home | 530.00p GBX (pence) | 0.00 (0.0%) | 112 | 530.00p | 530.00p | 526.00p | 530.00p | Close on Oct 30, 2026 |
| Frankfurt:88Q | €6.00 EUR | -0.35 (-5.5%) | — | €6.00 | €6.20 | €6.00 | €6.35 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:88Q
- Asset type
- Stock
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 21, 2026
Result of Retail Offer
Latest earnings call · Jun 29, 2026
4basebio (LSE:4BB) — Investor Presentation
Replay and transcript
Latest deck · May 20, 2026
Investor Presentation (May 2026)
Investor deck · 37 slides
Calls
Replays
4basebio (LSE:4BB) — Investor Presentation
Mon, Jun 29, 2026 · 12:00 PM ET
Watch Transcript4basebio (LSE:4BB) — Post AGM update
Mon, Jun 30, 2025 · 5:00 AM ET
Watch Transcript4basebio (LSE:4BB) — Investor Presentation
Tue, Jul 02, 2024 · 5:00 AM ET
Watch Transcript
Latest news
Financings
Private placement of new Ordinary Shares
Oct 20, 2026 · US$19.77M
Update: about £15M · RBC Capital Markets +1
Dealers: RBC Capital Markets (co-lead), Cavendish Capital Markets Limited (co-lead)
Buyers: M&G Investment Management Limited (465,830 Placing Shares); Elevage Medical Technologies LLC (256,504 Placing Shares); 2Invest AG (194,174 Subscription Shares in cash for approximately £1 million and 776,699 Subscription Shares for approximately £4 million by set-off against the Shareholder Loan); Amy Walker (9,708 Subscription Shares, £49,996.20); Richard Bungay (3,883 Subscription Shares, £19,997.45); Heikki Lanckriet (38,834 Subscription Shares, £199,995.10); Hansjörg Plaggemars (1,941 Subscription Shares, £9,996.15)
Insiders: Directors and officers Amy Walker, Richard Bungay, Heikki Lanckriet and Hansjörg Plaggemars subscribed for 54,366 Subscription Shares, aggregate gross proceeds of £0.3 million
New ordinary shares (Retail Offer Shares)
Oct 15, 2026 · US$658,908
Update: up to £500,000 · GBX 515 a share · Cavendish Capital Markets Limited
Dealers: Cavendish Capital Markets Limited
Use of proceeds: Commercial development, Q-Arc fit-out, R&D on turnaround times and yields, working capital and extending cash runway to H2 2028
Decks
Investor Presentation (May 2026)
Investor deck · 37 slides · May 20, 2026
Investor Presentation (June 2025)
Investor deck · 27 slides · Jun 30, 2025
Investor Presentation (July 2024)
Investor deck · 30 slides · Jul 2, 2024
Investor Presentation (June 2023)
Investor deck · 26 slides · Jun 16, 2023
4basebio PLC on 6ix
- News releases
- 24 in the last 12 months · 65 in all · newest Oct 21, 2026 · oldest 2021
- Calls
- 6 calls with a replay · 6 with a transcript · latest Jun 29, 2026
- Decks
- 8 decks · latest May 20, 2026
Where 4basebio PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:4BB · Home listing | LSE | United Kingdom | GBX |
| Lang & Schwarz:A3CWA4 | Lang & Schwarz | Germany | EUR |
| Xetra:88Q | Xetra | Germany | EUR |
| LS Exchange:A3CWA4 | LS Exchange | Germany | EUR |
| gettex:88Q | gettex | Germany | EUR |
| Frankfurt:88Q · This page | Frankfurt | Germany | EUR |
| OTC:FBSBF | OTC | United States | USD |
| Dusseldorf:88Q | Dusseldorf | Germany | EUR |
| Munich:88Q | Munich | Germany | EUR |
| Stuttgart:88Q | Stuttgart | Germany | EUR |
| Hamburg:88Q | Hamburg | Germany | EUR |
| Hanover:88Q | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about 4basebio PLC.